Polydex Pharmaceuticals Ltd. (OTCMKTS:POLXF – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $1.99 and traded as low as $1.9860. Polydex Pharmaceuticals shares last traded at $1.9860, with a volume of 2,000 shares.
Polydex Pharmaceuticals Stock Performance
The stock has a 50 day simple moving average of $1.99 and a 200 day simple moving average of $1.99.
Polydex Pharmaceuticals Company Profile
Polydex Pharmaceuticals Limited is a Canadian pharmaceutical company engaged in the development, manufacture and marketing of pharmaceutical products. The company’s operations have included products for both human and veterinary applications, with activities spanning pharmaceutical ingredients and finished dosage products.
Its product portfolio has included medicines and pharmaceutical chemicals used in areas such as anti-infective, antiseptic, analgesic, anesthetic and antihistamine treatments.
See Also
- Five stocks we like better than Polydex Pharmaceuticals
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
